The risk of COVID-19 in patients with psoriasis: A retrospective cohort study.

Wu, Jashin J; Liu, Jeffrey; Thatiparthi, Akshitha; Martin, Amylee; Egeberg, Alexander

Wu, Jashin J; Liu, Jeffrey; Thatiparthi, Akshitha; Martin, Amylee; Egeberg, Alexander.

Wu JJ; University of Miami Miller School of Medicine, Miami, Florida. Electronic address: jashinwu@gmail.com.
Liu J; Keck School of Medicine, University of Southern California, Los Angeles, California.
Thatiparthi A; Western University of Health Sciences, Pomona, California.
Martin A; School of Medicine, University of California Riverside, Riverside, California.
Egeberg A; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

J Am Acad Dermatol ; 87(6): 1395-1398, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2095535

Subject(s)

COVID-19; Psoriasis; Humans; Retrospective Studies; Psoriasis/complications; Psoriasis/epidemiology; Psoriasis/chemically induced; Thalidomide/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use

Keywords

COVID-19; apremilast; biologics; dermatology; methotrexate; psoriasis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Am Acad Dermatol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google